Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gaudet

Showing results (191-200 of 296) with videos related to

Pageof 30
Sort By:
Technical Innovations & Patient Support in Radiation Oncology|September 19, 2022
Clinical implementation of the first Cherenkov imaging system in a community-based hospitalErli Chen, Brian W Pogue, Petr Bruza, et al.
Cancer Research|September 7, 2018
Pooled Analysis of Nine Cohorts Reveals Breast Cancer Risk Factors by Tumor Molecular SubtypeMia M Gaudet, Gretchen L Gierach, Brian D Carter, et al.
American Journal of Epidemiology|February 22, 2023
Moving Toward Findable, Accessible, Interoperable, Reusable Practices in Epidemiologic ResearchMontserrat García-Closas, Thomas U Ahearn, Mia M Gaudet, et al.
American Journal of Epidemiology|October 3, 2024
Erratum: "Moving toward findable, accessible, interoperable, reusable practices in epidemiologic research"Montserrat García-Closas, Thomas U Ahearn, Mia M Gaudet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Germline BRCA mutations denote a clinicopathologic subset of prostate cancerDavid J Gallagher, Mia M Gaudet, Prodipto Pal, et al.
International Journal of Epidemiology|January 9, 2022
Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countriesAmber N Hurson, Parichoy Pal Choudhury, Chi Gao, et al.
Environmental Health Perspectives|January 13, 2010
Associations between polycyclic aromatic hydrocarbon-related exposures and p53 mutations in breast tumorsIrina Mordukhovich, Pavel Rossner, Mary Beth Terry, et al.
Archives of Environmental Health|June 23, 2006
Polycyclic aromatic hydrocarbon-DNA adducts and breast cancer: a pooled analysisMarilie D Gammon, Sharon K Sagiv, Sybil M Eng, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
No association between FTO or HHEX and endometrial cancer riskMia M Gaudet, Hannah P Yang, Jesus Gonzalez Bosquet, et al.
Cancer|February 8, 2017
The American Cancer Society's Cancer Prevention Study 3 (CPS-3): Recruitment, study design, and baseline characteristicsAlpa V Patel, Eric J Jacobs, Daniela M Dudas, et al.
Pageof 30

Showing results (191-200 of 296) with videos related to

Sort By:
Pageof 30
Technical Innovations & Patient Support in Radiation Oncology|September 19, 2022
Clinical implementation of the first Cherenkov imaging system in a community-based hospitalErli Chen, Brian W Pogue, Petr Bruza, et al.
Cancer Research|September 7, 2018
Pooled Analysis of Nine Cohorts Reveals Breast Cancer Risk Factors by Tumor Molecular SubtypeMia M Gaudet, Gretchen L Gierach, Brian D Carter, et al.
American Journal of Epidemiology|February 22, 2023
Moving Toward Findable, Accessible, Interoperable, Reusable Practices in Epidemiologic ResearchMontserrat García-Closas, Thomas U Ahearn, Mia M Gaudet, et al.
American Journal of Epidemiology|October 3, 2024
Erratum: "Moving toward findable, accessible, interoperable, reusable practices in epidemiologic research"Montserrat García-Closas, Thomas U Ahearn, Mia M Gaudet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Germline BRCA mutations denote a clinicopathologic subset of prostate cancerDavid J Gallagher, Mia M Gaudet, Prodipto Pal, et al.
International Journal of Epidemiology|January 9, 2022
Prospective evaluation of a breast-cancer risk model integrating classical risk factors and polygenic risk in 15 cohorts from six countriesAmber N Hurson, Parichoy Pal Choudhury, Chi Gao, et al.
Environmental Health Perspectives|January 13, 2010
Associations between polycyclic aromatic hydrocarbon-related exposures and p53 mutations in breast tumorsIrina Mordukhovich, Pavel Rossner, Mary Beth Terry, et al.
Archives of Environmental Health|June 23, 2006
Polycyclic aromatic hydrocarbon-DNA adducts and breast cancer: a pooled analysisMarilie D Gammon, Sharon K Sagiv, Sybil M Eng, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
No association between FTO or HHEX and endometrial cancer riskMia M Gaudet, Hannah P Yang, Jesus Gonzalez Bosquet, et al.
Cancer|February 8, 2017
The American Cancer Society's Cancer Prevention Study 3 (CPS-3): Recruitment, study design, and baseline characteristicsAlpa V Patel, Eric J Jacobs, Daniela M Dudas, et al.
Pageof 30